{
    "Trade/Device Name(s)": [
        "Glucose Shepherd Blood Glucose Monitoring System",
        "Glucose Shepherd Pro Blood Glucose Monitoring System"
    ],
    "Submitter Information": "BroadMaster Biotech Corporation",
    "510(k) Number": "K102316",
    "Predicate Device Reference 510(k) Number(s)": [
        "K072039"
    ],
    "Regulatory Class": "Class II, Class I, reserved",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "October 7, 2011",
    "Summary Letter Received Date": "September 30, 2011",
    "Submission Date": "September 28, 2011",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Glucose Shepherd Blood Glucose meter",
        "Glucose Shepherd Pro Blood Glucose meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancing Device"
    ],
    "Document Summary": "FDA 510(k) summary for Glucose Shepherd and Glucose Shepherd Pro blood glucose monitoring systems using amperometric detection in fresh capillary whole blood",
    "Indications for Use Summary": "Glucose Shepherd systems provide quantitative measurement of glucose in fresh capillary whole blood from various body sites to aid in monitoring effectiveness of diabetes control programs; not for diagnosis or screening of diabetes or use with neonates.",
    "fda_folder": "Clinical Chemistry"
}